Cardiac Pacemakers, Inc.

Last updated
Cardiac Pacemakers, Inc.
Company typePublic (NYSE:  BSX)
S&P 500 Component
Industry Medical equipment
Founded1971
Headquarters Saint Paul, Minnesota, USA
Products Medical devices
Services Medical technology

Cardiac Pacemakers, Inc. (CPI), doing business as Guidant Cardiac Rhythm Management, manufactured implantable cardiac rhythm management devices, such as pacemakers and defibrillators. It sold microprocessor-controlled insulin pumps and equipment to regulate heart rhythm. It developed therapies to treat irregular heartbeat. The company was founded in 1971 and is based in St. Paul, Minnesota. Cardiac Pacemakers, Inc. is a subsidiary of Boston Scientific Corporation. [1]

Contents

Early history

CPI was founded in February 1972 in St. Paul, Minnesota. The first $50,000 capitalization for CPI was raised from a phone booth on the Minneapolis skyway system. [2] They began designing and testing their implantable cardiac pacemaker powered with a new longer-life lithium battery in 1971. The first heart patient to receive a CPI pacemaker emerged from surgery in June 1973. Within two years, the upstart company that challenged Medtronic had sold approximately 8,500 pacemakers. [3]

Medtronic at the time had 65% of the artificial pacemaker market. CPI was the first spin-off from Medtronic. It competition using the world's first lithium-powered pacemaker. Medtronic's market share plummeted to 35%. [4] [5]

Founding partners Anthony Adducci, Manny Villafaña, Jim Baustert, and Art Schwalm, were former Medtronic employees. Lawsuits ensued, all settled out of court. [6]

Acquisition

Cardiac Pacemaker, Inc. Microlyth Pacemaker CPI Microlyth Pacemaker.jpg
Cardiac Pacemaker, Inc. Microlyth Pacemaker

In early 1978, CPI was concerned about a friendly takeover attempt. Despite impressive sales, the company's stock price had fluctuated wildly the year before, dropping from $33 to $11 per share. Some speculated that the stock was being sold short, while others attributed the price to the natural volatility of high-tech stock. As a one-product company, CPI was susceptible to changing market conditions, and its founders knew they needed to diversify. They considered two options: acquiring other medical device companies or being acquired themselves. They chose the latter.

Several companies expressed interest in acquiring CPI, including 3M, American Hospital Supply, Pfizer, and Johnson & Johnson. However, Eli Lilly, one of America's premier pharmaceutical companies, was the most enthusiastic suitor. "Lilly had the research expertise, highly compatible interests, and similar values," Anthony Adducci recalls. "At CPI, we haven't been able to dedicate the dollars and time necessary to develop new products beyond our staple lithium-powered pacemaker. Lilly was a $2 billion company. We knew they had tremendous resources, especially in research and development." [6] Additionally, Eli Lilly and CPI were already interested in developing insulin pumps, and Lilly was working with cardiovascular drugs, a natural link to CPI's heart pacemaker business.

Before the final negotiations in late 1978, there were numerous flights between Minneapolis and Indianapolis for CPI principals and representatives of Piper, Jaffray & Hopwood's corporate finance department. Finally, both sides sat down at the bargaining table at a motel in suburban Bloomington, Minnesota – Lilly, the pharmaceutical giant, and CPI, the upstart pacemaker company. CPI's negotiation team included Anthony Adducci, Art Schwalm, Tom King, and Hunt Greene.

The company sold 8,500 pacemakers increasing sales from zero in 1972 to over $47 million. In December 1978, it was acquired by Eli Lilly and Company for $127 million. [7]

Lithium battery

CPI designed and manufactured the world's first pacemaker with a lithium anode and a lithium-iodide electrolyte solid-state battery. The pacemaker structure is enclosed in a hermetically sealed metallic enclosure, allowing electrode leads to pass in a sealed relationship. The surface of the casing is polished metal, with a zone through which the external electrode leads pass. [8]

World's first lithium battery-powered pacemaker CPI Pacemaker.jpg
World's first lithium battery-powered pacemaker
Original Lithium-iodine bipolar pulse generator CPI Bipolar Pulse Generator 04.jpg
Original Lithium-iodine bipolar pulse generator

The Lithium-iodide or lithium anode cells revolutionized the medical industry by increasing the pacemaker life from 1 year up to 11 years. It became the standard for pacemaker designs.

Related Research Articles

<span class="mw-page-title-main">Artificial cardiac pacemaker</span> Medical device

An artificial cardiac pacemaker, commonly referred to as simply a pacemaker, is an implanted medical device that generates electrical pulses delivered by electrodes to one or more of the chambers of the heart. Each pulse causes the targeted chamber(s) to contract and pump blood, thus regulating the function of the electrical conduction system of the heart.

<span class="mw-page-title-main">Defibrillation</span> Treatment for life-threatening cardiac arrhythmias

Defibrillation is a treatment for life-threatening cardiac arrhythmias, specifically ventricular fibrillation (V-Fib) and non-perfusing ventricular tachycardia (V-Tach). A defibrillator delivers a dose of electric current to the heart. Although not fully understood, this process depolarizes a large amount of the heart muscle, ending the arrhythmia. Subsequently, the body's natural pacemaker in the sinoatrial node of the heart is able to re-establish normal sinus rhythm. A heart which is in asystole (flatline) cannot be restarted by a defibrillator; it would be treated only by cardiopulmonary resuscitation (CPR) and medication, and then by cardioversion or defibrillation if it converts into a shockable rhythm.

<span class="mw-page-title-main">Implantable cardioverter-defibrillator</span> Medical device

An implantable cardioverter-defibrillator (ICD) or automated implantable cardioverter defibrillator (AICD) is a device implantable inside the body, able to perform defibrillation, and depending on the type, cardioversion and pacing of the heart. The ICD is the first-line treatment and prophylactic therapy for patients at risk for sudden cardiac death due to ventricular fibrillation and ventricular tachycardia.

Wilson Greatbatch was an American engineer and pioneering inventor. He held more than 325 patents and was a member of the National Inventors Hall of Fame and a recipient of the Lemelson–MIT Prize and the National Medal of Technology and Innovation (1990).

<span class="mw-page-title-main">Medtronic</span> Irish tax-registered medical device company

Medtronic plc is an Irish medical device company. The company's operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies.

Guidant Corporation, part of Boston Scientific and Abbott Labs, designs and manufactures artificial cardiac pacemakers, implantable cardioverter-defibrillators, stents, and other cardiovascular medical products. Their company headquarters is located in Indianapolis, Indiana. Their main competitors are Medtronic, St. Jude Medical, and Johnson and Johnson.

<span class="mw-page-title-main">Earl Bakken</span> Future thought innovator supporting holistic healthcare options

Earl Elmer Bakken was an American engineer, businessman and philanthropist of Dutch and Norwegian American ancestry. He founded Medtronic, where he developed the first external, battery-operated, transistorized, wearable artificial pacemaker in 1957.

Telectronics Pty Ltd was an Australian company best known for its role in developing the pacemaker. It was located in Lane Cove, Sydney. In 1988 the business was acquired by Pacific Dunlop. However, legal claims resulting from the sale of faulty pacemaker electrode leads inherited by the company in acquisition of Cordis Corporation of Miami led to eventual sale of the assets of the company and Pacific Dunlop restructuring itself into Ansell.

St. Jude Medical, Inc. was an American global medical device company headquartered in Little Canada, Minnesota, U.S., a suburb of Saint Paul. The company had more than 20 principal operations and manufacturing facilities worldwide with products sold in more than 100 countries. Its major markets include the United States, Europe, Latin America and Asia-Pacific. The company was named after Jude the Apostle, the patron saint of lost causes.

Barouh Vojtec Berkovits was one of the pioneers of bio-engineering, particularly the cardiac defibrillator and artificial cardiac pacemaker. In particular, Berkovits invented the "demand pacemaker" and the DC defibrillator.

Clinical cardiac electrophysiology, is a branch of the medical specialty of cardiology concerned with the study and treatment of rhythm disorders of the heart. Cardiologists with expertise in this area are usually referred to as electrophysiologists. Electrophysiologists are trained in the mechanism, function, and performance of the electrical activities of the heart. Electrophysiologists work closely with other cardiologists and cardiac surgeons to assist or guide therapy for heart rhythm disturbances (arrhythmias). They are trained to perform interventional and surgical procedures to treat cardiac arrhythmia.

<span class="mw-page-title-main">Anthony Adducci</span> Inventor and entrepreneur

Anthony J. Adducci was a pioneer of the medical device industry in Minnesota. He is best known for co-founding Cardiac Pacemakers, Inc., the company that manufactured the world's first lithium battery powered artificial pacemaker. The lithium-iodide cell revolutionized the medical industry and is now the standard cell for pacemakers.

<span class="mw-page-title-main">Transcutaneous pacing</span> Method of temporary stabilizing an individuals heartbeat

Transcutaneous pacing (TCP), also called external pacing, is a temporary means of pacing a patient's heart during a medical emergency. It should not be confused with defibrillation using a manual or automatic defibrillator, though some newer defibrillators can do both, and pads and an electrical stimulus to the heart are used in transcutaneous pacing and defibrillation. Transcutaneous pacing is accomplished by delivering pulses of electric current through the patient's chest, which stimulates the heart to contract.

<span class="mw-page-title-main">Mir Imran</span>

Mir A. Imran, is an Indian medical inventor, entrepreneur and venture capitalist. Imran has formed over 20 medical device companies since the early 1980s and holds over 400 patents. He is known for his role in developing the world's first implantable cardiac defibrillator.

Morton Maimon Mower was an American cardiologist specializing in electrophysiology and the co-inventor of the automatic implantable cardioverter defibrillator. He served in several professional capacities at Sinai Hospital and Cardiac Pacemakers Inc. In 1996, he became the chairman and chief executive officer of Mower Research Associates. He was inducted into the National Inventors Hall of Fame in 2002 for the development of the automatic implantable cardioverter defibrillator with Michel Mirowski in the 1970s. He continued his research in the biomechanical engineering laboratories at Johns Hopkins University.

Alois A. Langer is an American biomedical engineer best known as one of the co-inventors of the Implantable Cardioverter Defibrillator (ICD).

<span class="mw-page-title-main">Cardiac resynchronization therapy</span> Treatment for heart failure

Cardiac resynchronisation therapy is the insertion of electrodes in the left and right ventricles of the heart, as well as on occasion the right atrium, to treat heart failure by coordinating the function of the left and right ventricles via a pacemaker, a small device inserted into the anterior chest wall.

Biotronik is a limited partnership multi-national cardiovascular biomedical research and technology company, headquartered in Berlin, Germany.

Cameron Health was a medical device developer based in San Clemente, California, USA. Cameron Health had its European office, Cameron Health BV, in Arnhem, The Netherlands. The privately held company's focus was on a new generation of minimally invasive implantable cardioverter-defibrillator (ICD) which they called a Subcutaneous Implantable Defibrillator (S-ICD). Cameron Health's approach avoided implanting transvenous leads into the heart, which had been the usual procedure for cardiac devices. Instead, the Cameron ICD was entirely implanted outside the thoracic wall.

Manny Villafaña, a child of Puerto Rican immigrants, he attended Cardinal Hayes High School in the Bronx. He began his medical career in 1964 at medical-device exporter Picker International. In 1967, he was hired away from Picker by Earl Bakken, CEO of Medtronic to become their first international sales administrator.

References

  1. "Cardiac Pacemakers Inc - Company Profile and News". Archived from the original on October 11, 2014.
  2. St. Anthony N: Ingenuity and integrity mark Medtronic co-founder. Minneapolis Star and Tribune, Feb 11, 1985, pp M1-3
  3. Implantable pacemaker : High Technology Entrepreneurship and Strategy. February 2002; by Prof. Ron Adner
  4. Mundale S: Blessed are the pacemakers. Corporate Report Minnesota, Nov 1981, pp 63-70
  5. Jeffrey, Kirk (April 2003). Machines in Our Hearts: The Cardiac Pacemaker, the Implantable Defibrillator, and American Health Care. ISBN   9780801876165.
  6. 1 2 Fiedler T: Straight from the heart. Minnesota Business Journal, Feb 1985, p p 24-35
  7. Ticker Tape Tales. Piper, Jaffray & Hopwood. 1985. pp. 194–196.
  8. "Metal-enclosed cardiac pacer with solid-state power source". US3822707 A.